Clinical trialNCT00209092CompletedPhase 2Interventional

Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer

SponsorEmory UniversityEnrollment51Breast Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to find out if the combination of docetaxel and capecitabine can shrink the size of breast tumors and preserve the breast.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Amelia Zelnak, MD
Emory University Winship Cancer Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Emory Crawford Long Hospital
Atlanta, Georgia, United States
Emory University Winship Cancer Institute
Atlanta, Georgia, United States
Grady Memorial Hospital
Atlanta, Georgia, United States
Augusta Oncology Associates, Pc 1348 Walton Way, Ste. 4300
Augusta, Georgia, United States
Augusta Oncology Associates, Pc 3696 Wheeler Road
Augusta, Georgia, United States
Wellstar Health System-Georgia Cancer Specialists
Austell, Georgia, United States
Wellstar Health System-Northwest Georgia Oncology Center, Pc
Austell, Georgia, United States
Wellstar Health System-Northwest Georgia Oncology Center, Pc
Carrollton, Georgia, United States
John B. Amos Cancer Center
Columbus, Georgia, United States
Suburban Hematology-Oncology Associates, Pc
Duluth, Georgia, United States
South Atlanta Hematology-Oncology Group
East Point, Georgia, United States
Suburban Hematology-Oncology Associates, Pc
Lawrenceville, Georgia, United States
Central Georgia Cancer Care, Pc
Macon, Georgia, United States
Wellstar Health System-Georgia Cancer Specialists
Marietta, Georgia, United States
Wellstar Health System-Northwest Georgia Oncology Center, Pc
Marietta, Georgia, United States
South Atlanta Hematology-Oncology Group
Riverdale, Georgia, United States
Suburban Hematology-Oncology Associates, Pc
Snellville, Georgia, United States
South Atlanta Hematology-Oncology Group
Stockbridge, Georgia, United States
Central Georgia Cancer Care, Pc
Warner Robins, Georgia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Capecitabine →Docetaxel →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Aug 2006
Primary completion: 31 Jul 2009
Completion: 31 Oct 2012
Last update posted: 27 Mar 2015
Registered enrollment: 51
Registry id: NCT00209092

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.